Why Illumina's MRD Duplex Workflow Matters For The Stock Illumina (ILMN) has put its molecular residual disease research ambitions front and center with an early access duplex sequencing workflow that...
Source LinkWhy Illumina's MRD Duplex Workflow Matters For The Stock Illumina (ILMN) has put its molecular residual disease research ambitions front and center with an early access duplex sequencing workflow that...
Source Link
Comments